REPLIGEN CORP - COMMON STOCK (RGEN)

Q3 2015 13F Holders as of 9/30/2015

Type / Class
Equity / COMMON STOCK
Shares outstanding
56.2M
Number of holders
186
Total 13F shares, excl. options
30M
Shares change
-483K
Total reported value, excl. options
$835M
Value change
-$19.6M
Put/Call ratio
0.51
Number of buys
107
Number of sells
-72
Price
$27.85

Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2015

205 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q3 2015.
REPLIGEN CORP - COMMON STOCK (RGEN) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30M shares of 56.2M outstanding shares and own 53.31% of the company stock.
Largest 10 shareholders include FMR LLC (2.61M shares), BlackRock Fund Advisors (2.43M shares), Invesco Ltd. (1.96M shares), RS INVESTMENT MANAGEMENT CO LLC (1.41M shares), OPPENHEIMER FUNDS INC (1.4M shares), VANGUARD GROUP INC (1.34M shares), STATE STREET CORP (1.29M shares), DIMENSIONAL FUND ADVISORS LP (1.23M shares), RENAISSANCE TECHNOLOGIES LLC (875K shares), and WELLS FARGO & COMPANY/MN (842K shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.